Skip to main content

PDLI Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

PDL BioPharma, Inc. News

Neos Therapeutics Stock Soars on 3rd Unsolicited Buyout Offer From PDL BioPharma

Pharmaceutical company Neos received an offer for $10.25 per share, which would value the deal around $288 million. It's the third time PDL has tried to make a deal.

Biotech Movers: Sarepta, Paratek, PDL BioPharma

Sarepta Therapeutics, Paratek Pharmaceuticals and PDL BioPharma were among the biotech stock movers in premarket trading on Monday.

Biotech movers: Argos plummets 72%

Also falling was Global Blood Therapeutics.

Eli Lilly's Alzheimer's Drug Study Results are Coming -- Here's what investors need to know

In a few weeks, investors will know if Lilly's solanezumab is a groundbreaking treatment for Alzheimer's or another drug casualty to a disease that has eluded pharmaceutical companies for years.

PDL BioPharma (PDLI) Stock Plummets on Q2 Revenue Miss

Following Thursday's closing bell, PDL BioPharma (PDLI) reported lower-than-expected revenue for the 2016 second quarter.

Breaking News

Elon Musk Says Only Two Things Could Make Him Leave Tesla

Tesla CEO Musk discusses succession plans and Twitter with shareholders.

Caesars Inches Closer to Huge Las Vegas Strip Move

The company has made clear what it plans on the Las Vegas Strip, but it has a fast-approaching deadline.

Elon Musk Has Bad News About Tesla's Cybertruck

Long-delayed futuristic looking electric vehicle will be in production by the middle of 2023